Logo image of UBI.PA

UBISOFT ENTERTAINMENT (UBI.PA) Stock Fundamental Analysis

Europe - EPA:UBI - FR0000054470 - Common Stock

9.996 EUR
-0.07 (-0.73%)
Last: 10/2/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, UBI scores 3 out of 10 in our fundamental rating. UBI was compared to 43 industry peers in the Entertainment industry. The financial health of UBI is average, but there are quite some concerns on its profitability. UBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

UBI had negative earnings in the past year.
UBI had a positive operating cash flow in the past year.
In multiple years UBI reported negative net income over the last 5 years.
UBI had a positive operating cash flow in each of the past 5 years.
UBI.PA Yearly Net Income VS EBIT VS OCF VS FCFUBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

With a Return On Assets value of -3.38%, UBI perfoms like the industry average, outperforming 41.86% of the companies in the same industry.
With a Return On Equity value of -8.86%, UBI perfoms like the industry average, outperforming 48.84% of the companies in the same industry.
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
UBI.PA Yearly ROA, ROE, ROICUBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

UBI has a better Gross Margin (89.33%) than 74.42% of its industry peers.
UBI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for UBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
UBI.PA Yearly Profit, Operating, Gross MarginsUBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

UBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
UBI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, UBI has more shares outstanding
Compared to 1 year ago, UBI has an improved debt to assets ratio.
UBI.PA Yearly Shares OutstandingUBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
UBI.PA Yearly Total Debt VS Total AssetsUBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.15, we must say that UBI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.15, UBI is in line with its industry, outperforming 51.16% of the companies in the same industry.
The Debt to FCF ratio of UBI is 2.24, which is a good value as it means it would take UBI, 2.24 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UBI (2.24) is better than 67.44% of its industry peers.
A Debt/Equity ratio of 1.02 is on the high side and indicates that UBI has dependencies on debt financing.
UBI has a worse Debt to Equity ratio (1.02) than 62.79% of its industry peers.
Even though the debt/equity ratio score it not favorable for UBI, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Altman-Z 1.15
ROIC/WACCN/A
WACC5.49%
UBI.PA Yearly LT Debt VS Equity VS FCFUBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

UBI has a Current Ratio of 1.68. This is a normal value and indicates that UBI is financially healthy and should not expect problems in meeting its short term obligations.
UBI has a better Current ratio (1.68) than 83.72% of its industry peers.
A Quick Ratio of 1.68 indicates that UBI should not have too much problems paying its short term obligations.
UBI has a better Quick ratio (1.68) than 83.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
UBI.PA Yearly Current Assets VS Current LiabilitesUBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

3

3. Growth

3.1 Past

UBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.28%.
UBI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.46%.
UBI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.56% yearly.
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%

3.2 Future

Based on estimates for the next years, UBI will show a very strong growth in Earnings Per Share. The EPS will grow by 33.68% on average per year.
The Revenue is expected to grow by 5.22% on average over the next years.
EPS Next Y30.99%
EPS Next 2Y75.71%
EPS Next 3Y55.76%
EPS Next 5Y33.68%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y4.61%
Revenue Next 5Y5.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UBI.PA Yearly Revenue VS EstimatesUBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
UBI.PA Yearly EPS VS EstimatesUBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UBI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for UBI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBI.PA Price Earnings VS Forward Price EarningsUBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

81.40% of the companies in the same industry are more expensive than UBI, based on the Enterprise Value to EBITDA ratio.
UBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. UBI is cheaper than 97.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.37
EV/EBITDA 3.69
UBI.PA Per share dataUBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

UBI's earnings are expected to grow with 55.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.71%
EPS Next 3Y55.76%

More info and screens

0

5. Dividend

5.1 Amount

UBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UBISOFT ENTERTAINMENT

EPA:UBI (10/2/2025, 7:00:00 PM)

9.996

-0.07 (-0.73%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-22 2025-07-22
Earnings (Next)10-23 2025-10-23
Inst Owners40.77%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.33B
Analysts55.24
Price Target11.42 (14.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-144.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.7
P/FCF 1.37
P/OCF 1.31
P/B 0.74
P/tB N/A
EV/EBITDA 3.69
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)7.29
FCFY72.96%
OCF(TTM)7.61
OCFY76.12%
SpS14.32
BVpS13.54
TBVpS-3.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.38%
ROE -8.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.33%
FCFM 50.92%
ROA(3y)-3.63%
ROA(5y)-1.44%
ROE(3y)-11.29%
ROE(5y)-4.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.21%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 2.24
Debt/EBITDA 2.7
Cap/Depr 5.9%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion 148.22%
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 1.15
F-Score3
WACC5.49%
ROIC/WACCN/A
Cap/Depr(3y)8.81%
Cap/Depr(5y)10.92%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.33%
EPS Next Y30.99%
EPS Next 2Y75.71%
EPS Next 3Y55.76%
EPS Next 5Y33.68%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-3.68%
Revenue growth 5Y3.56%
Sales Q2Q%-19.67%
Revenue Next Year-4.24%
Revenue Next 2Y4.07%
Revenue Next 3Y4.61%
Revenue Next 5Y5.22%
EBIT growth 1Y-109.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1298.26%
EBIT Next 3Y169.04%
EBIT Next 5Y83.7%
FCF growth 1Y129.47%
FCF growth 3Y16.28%
FCF growth 5Y14.31%
OCF growth 1Y87.67%
OCF growth 3Y12.65%
OCF growth 5Y10.94%